GPCRNasdaq United States
Market cap
$3.777 B
$53.14 +0.99%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$141.2M
Loss-making
Shares outstanding
213,929,572
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Structure Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.